Increased consumption of fruit and vegetables can represent an easy strategy to significantly reduce the incidence of cancer. We recently demonstrated that the flavonoid quercetin, naturally present in the diet and belonging to the class of phytochemicals, is able to sensitize several leukemia cell lines and B cells isolated from patients affected by chronic lymphocytic leukemia (B-CLL), in addition to apoptotic inducers (anti-CD95 and rTRAIL). Further, it potentiates the effect of fludarabine, a first-line chemotherapeutic drug used against CLL. The proapoptotic activity of quercetin in cell lines and B-CLL is related to the expression and activity of Mcl-1-antiapoptotic proteins belonging to the Bcl-2 family. Quercetin downregulates Mcl-1 mRNA and protein levels acting on mRNA stability and protein degradation. Considering the low toxicity of the flavonoids toward normal peripheral blood cells, our experimental results are in favor of a potential use of quercetin in adjuvant chemotherapy in CLL or other types of cancer. © 2012 New York Academy of Sciences.

Dietary polyphenols in cancer prevention: The example of the flavonoid quercetin in leukemia

Spagnuolo C;Russo M;Bilotto S;Tedesco I;Laratta B;Russo;G L
2012

Abstract

Increased consumption of fruit and vegetables can represent an easy strategy to significantly reduce the incidence of cancer. We recently demonstrated that the flavonoid quercetin, naturally present in the diet and belonging to the class of phytochemicals, is able to sensitize several leukemia cell lines and B cells isolated from patients affected by chronic lymphocytic leukemia (B-CLL), in addition to apoptotic inducers (anti-CD95 and rTRAIL). Further, it potentiates the effect of fludarabine, a first-line chemotherapeutic drug used against CLL. The proapoptotic activity of quercetin in cell lines and B-CLL is related to the expression and activity of Mcl-1-antiapoptotic proteins belonging to the Bcl-2 family. Quercetin downregulates Mcl-1 mRNA and protein levels acting on mRNA stability and protein degradation. Considering the low toxicity of the flavonoids toward normal peripheral blood cells, our experimental results are in favor of a potential use of quercetin in adjuvant chemotherapy in CLL or other types of cancer. © 2012 New York Academy of Sciences.
2012
Istituto di Chimica Biomolecolare - ICB - Sede Pozzuoli
Istituto di Scienze dell'Alimentazione - ISA
antineoplastic agent
Fas antigen
fludarabine
messenger RNA
polyphenol
protein bcl 2
protein mcl 1
quercetin
recombinant tumor necrosis factor related apoptosis inducing ligand
tumor necrosis factor related apoptosis inducing ligand
acute granulocytic leukemia
acute lymphocytic leukemia
adjuvant therapy
antiproliferative activity
apoptosis
article
B lymphocyte
cancer
chronic lymphatic leukemia
cytotoxicity
drug bioavailability
drug metabolism
drug uptake
human
leukemia cell line
nephrotoxicity
peripheral blood mononuclear cell
protein degradation
protein expression
RNA stability
Animals
Antineoplastic Agents
Phytogenic
Chemotherapy
Adjuvant
Diet
Flavonoids
Humans
Leukemia
Models
Biological
Neoplasms
Polyphenols
Quercetin
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/207051
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 130
  • ???jsp.display-item.citation.isi??? ND
social impact